New York Medical College
Clinical trials sponsored by New York Medical College, explained in plain language.
-
Immune cell therapy shows promise against stubborn BK virus in young transplant patients
Disease control Recruiting nowThis study tests whether immune cells from a donor can safely lower BK virus levels in children, adolescents, and young adults who have a viral infection that won't go away after a stem cell or organ transplant, or who have a weak immune system. About 40 participants will receive…
Phase: PHASE1, PHASE2 • Sponsor: New York Medical College • Aim: Disease control
Last updated Jun 08, 2026 13:05 UTC
-
Higher drug doses may help transplant patients with stubborn liver disease
Disease control Recruiting nowThis study is for people who developed a serious liver condition called sinusoidal obstructive syndrome (SOS) after a stem cell transplant and did not get better with the usual dose of a drug called defibrotide. Researchers want to see if giving higher doses of defibrotide is saf…
Phase: PHASE2 • Sponsor: New York Medical College • Aim: Disease control
Last updated Jun 08, 2026 13:04 UTC